EDGAR Filing Documents for 0001415889-16-005729

Form 8-K - Current report:

SEC Accession No. 0001415889-16-005729

Filing Date

2016-05-04

Accepted

2016-05-04 15:35:16

Documents

Period of Report

2016-04-29

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ecte8k_apr292016.htm	8-K	45882
2	AMENDMENT TO CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF ITS SERIES F	ex3-1.htm	EX-3.1	16753
3	FORM OF NOTE	ex10-2.htm	EX-10.2	175657
4	FORM OF WARRANT	ex10-3.htm	EX-10.3	115668
5	PROMISSORY NOTE, DATED APRIL 29, 2016, ISSUED TO BEIJING YI TANG BIO SCIENCE & T	ex10-4.htm	EX-10.4	17069
6	PROMISSORY NOTE, DATED MAY 2, 2016, ISSUED TO THE COMPANY BY BEIJING YI TANG BIO	ex10-5.htm	EX-10.5	15213
	Complete submission text file	0001415889-16-005729.txt		387985

Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830

Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)